您好，歡迎來(lái)到拜力生物網(wǎng)站！請(qǐng)登錄注冊(cè)

我的訂單 | 聯(lián)系我們 | 在線客服QQ：3012681483 | 客服電話：400-968-7988 | 工作時(shí)間：08:30-17:30

主營(yíng)產(chǎn)品： ELISA試劑盒、抗體、補(bǔ)體血清、兔補(bǔ)體、干擾素、小鼠測(cè)溫儀、進(jìn)口試劑、Quidel代理、Swant代理、PBL Assay Science代理

所在位置：首頁(yè) > 產(chǎn)品中心 > Innovagen > Innovagen產(chǎn)品

訂購(gòu)信息

上海拜力生物科技公司

Tel:400-968-7988 021-33779008

LL-37 scrambled peptide

品牌：Innovagen AB

貨號(hào)：SP-LL37SCR-5

規(guī)格：5 mg

貨期：

立即購(gòu)買加入購(gòu)物車

LL-37 scrambled peptide SP-LL37SCR-5

商品詳情參考文獻(xiàn) 相關(guān)資料

LL-37 scrambled peptide

Name		LL-37 scrambled
Sequence		GLKLRFEFSKIKGEFLKTPEVRFRDIKLKDNRISVQR
3-letter-code		Gly - Leu - Lys - Leu - Arg - Phe - Glu - Phe - Ser - Lys - Ile - Lys - Gly - Glu - Phe - Leu - Lys - Thr - Pro - Glu - Val - Arg - Phe - Arg - Asp - Ile - Lys - Leu - Lys - Asp - Asn - Arg - Ile - Ser - Val - Gln - Arg
Notes		Scrambled version of LL-37.
Molecular weight		4493.33
Counter ion		TFA
Solubilization		Soluble in pure water.
Description		The cathelicidin anti-microbial peptide LL-37 corresponds to aa 134-170 of the human cationic antimicrobial protein 18 (hCAP18). This peptide is the scrambled version.
References		L. Bandholtz, G. Jacobsson Ekman, M. Vilhelmsson, E. Buentke, B. Agerberth, A. Scheynius, G. H. Gudmundsson. 2006. Antimicrobial Peptide LL-37 Internalized by Immature Human Dendritic Cells Alters their Phenotype Scandinavian Journal of Immunology 63 (6), 410?419.

Amount	Cat.No.	Unit price
1 mg	SP-LL37SCR-1	420 USD	BUY
5 mg	SP-LL37SCR-5	1850 USD	BUY

For larger amounts please inquire.

The catalog entry for LL-37 may contain more information and related peptides.

Name
LL-37 scrambled 5-FAM		5-Carboxyfluorescein on N-terminus.
LL-37 scrambled biotin		Biotin via a 6-carbon spacer (Ahx) on N-terminus.

Name		Sequence
Cys-LL-37		CLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
Cys-LL-37-Cys		CLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESC
LL-37 (acetate)		LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
LL-37 : Ultra-pure		LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
LL-37 Citrulline		LLGDFF(Cit )KSKEKIGKE FK(Cit)IVQ (Cit)IKDFL (Cit)NLVP( Cit)TES
LL-37 FK-13		FKRIVQRIKDFLR
LL-37 FKR		FKRIVQRIKDFLRNLVPRTES
LL-37 GKE		GKEFKRIVQRIKDFLRNLVPR
LL-37 KRI		KRIVQRIKDFLRNLVPRTES
LL-37 LLG		LLGDFFRKSKEKIGKEFKRIV
LL-37 RKS		RKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
LL-37 SKE		SKEKIGKEFKRIVQRIKDFLR
LL-37-Cys		LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESC